期刊文献+

血管紧张素Ⅱ引起的靶器官损伤与单核细胞趋化因子-1

Angiotensin Ⅱ-induced Target Organ Damage and Monocyte Chemoattractant Protein-1
下载PDF
导出
摘要 肾素-血管紧张素系统(RAS)过度激活时,血管紧张素Ⅱ(AngⅡ)水平的升高在多种心血管疾病、肝脏、肾脏疾病的发病中具有重要的作用。研究表明,AngⅡ可以促进多种炎症因子的分泌,炎症因子参与了AngⅡ引起的靶器官损伤过程。其中单核细胞趋化因子-1(MCP-1)被认为是介导AngⅡ致靶器官损伤的一个关键因子,它与AngⅡ参与的多种疾病有关。AngⅡ通过激活核因子-kappa B(NF-κB)调控MCP-1的基因转录。除NF-κB之外,AngⅡ还可能通过多条信号途径调节MCP-1的表达。现对AngⅡ对MCP-1的调节,及MCP-1在介导AngⅡ的靶器官损伤中的作用等问题作一综述。 Increasing in angiotensin Ⅱ(AngⅡ) as renin-angiotensin system over activated plays a critical role in the pathogenesis of a wide spectrum of diseases,including cardiovascular diseases,liver and renal damages.Researches have suggested that the increased AngⅡ can promote productions of numerous inflammatory factors that mediated the target organ damage caused by AngⅡ.Among these factors,monocyte chemoattractant protein-1(MCP-1) is considered as the most important mediator of AngⅡ.It is associated with a number of diseases that AngⅡ is involved in.AngⅡ may modulate transcription of MCP-1 gene through activation of nuclear factor-kappa B(NF-κB).Additionally,some other signal pathways may participate in MCP-1 formation induced by AngⅡ.This paper briefly reviews the modulation of AngⅡ on MCP-1 and the action of MCP-1 in AngⅡ induced target organ damage.
出处 《心血管病学进展》 CAS 2006年第z1期81-83,共3页 Advances in Cardiovascular Diseases
关键词 血管紧张素Ⅱ 单核细胞趋化因子-1 靶器官损伤 angiotensin Ⅱ monocyte chemoattractant protein-1 target organ damage
  • 相关文献

参考文献26

  • 1[1]Kanno K,Tazuma S,Nishioka T,et al.Angiotensin Ⅱ participates in hepatic inflammation and fibrosis through MCP-1 expression[J].Dig Dis Sci,2005,50(5):942-948.
  • 2[2]Zhuo JL.Monocyte chemoattactant protein-1:A key mediator of angiotensin Ⅱ-induced target organ damage in hypertensive heart disease[J]? J Hypertens,2004,22:451-454.
  • 3[3]Luft FC,Mervaala E,Muller DN,et al.Hypertension-induced end-organ damage:A new transgenic approach to an old problem[J].Hypertension,1999,33:212-218.
  • 4[4]Cushman WC.Are there benefits to specific antihypertensive drug therapy[J]? Am J Hypertens,2003,16:31-35.
  • 5[5]Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients[J].N Engl J Med,2000,342:145-153.
  • 6[6]Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):A randomized trial against atenolol[J].Lancet,2002,359:995-1003.
  • 7[7]Ruiz OM,Ruperez M,Lorenzo O,et al.Angiotensin Ⅱ regulates the synthesis of proinflammatory cytokines and chemokines in the kidney[J].Kidney Int,2002,62(suppl 82):12-22.
  • 8[8]Hisada Y,Sygaya T,Yamanouchi M,et al.Angiotensin Ⅱ plays a pathologic role in immune-mediated renal injury in mice[J].J Clin Invest,1999,103:627-635.
  • 9[9]Vaziri ND,Xu ZG,Shahkarami A,et al.Role of AT-1 receptor in regulation of vascular MCP-1,IL-6,PAI-1,MAP kinase,and matrix expressions in obesity[J].Kidney Int,2005,68:2787-2793.
  • 10[10]Tanifuji C,Suzuki Y,Geot WM,et al.Reactive oxygen species-mediated signaling pathways in angiotensin Ⅱ-induced MCP-1 expression of proximal tubular cells[J].Antioxid Redox Signal,2005,7(9-10):1261-1268.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部